Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Molly McVoy & Jennifer B. Levin. (2023) Updated strategies for the management of poor medication adherence in patients with bipolar disorder. Expert Review of Neurotherapeutics 23:4, pages 365-376.
Read now
Read now
Michael J Doane, Kristine Ogden, Leona Bessonova, Amy K O’Sullivan & Mauricio Tohen. (2021) Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review. Neuropsychiatric Disease and Treatment 17, pages 515-531.
Read now
Read now
Georgios D. Kotzalidis, Chiara Rapinesi, Chiara Chetoni & Sergio De Filippis. (2021) Aripiprazole IM depot as an option for the treatment of bipolar disorder. Expert Opinion on Pharmacotherapy 22:11, pages 1407-1416.
Read now
Read now
Xiaoli Niu, Phani Veeranki, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, G. Rhys Williams & Antony Loebel. (2021) Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data. Current Medical Research and Opinion 37:5, pages 839-846.
Read now
Read now
Articles from other publishers (24)
Motahareh Sadat Mirhaj Mohammadabadi, Homa Mohammadsadeghi, Mehrdad Eftekhar Adrebili, Zahra Partovi Kolour, Fatemeh Kashaninasab, Vahid Rashedi & Mohammadreza Shalbafan. (2022) Factors associated with pharmacological and psychotherapy treatments adherence in patients with borderline personality disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Minhua Chen, Lina Zhou, Li Ye, Gelin Lin, Yongli Pang, Liyun Lu & Xianglan Wang. (2022) Initial adherence by psychiatric outpatients in a general hospital and relevant personal factors. BMC Psychiatry 22:1.
Crossref
Crossref
Kang Sim & Ross J Baldessarini. (2022) Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology. European Neuropsychopharmacology 60, pages 19-21.
Crossref
Crossref
Rakesh Jain, Amanda M. Kong, Patrick Gillard & Amanda Harrington. (2022) Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis. Advances in Therapy 39:6, pages 2578-2595.
Crossref
Crossref
Nien Chen Li, Matthew Alcusky, Grace A. Masters & Arlene S. Ash. (2022) Association of Social Determinants of Health With Adherence to Second-generation Antipsychotics for People With Bipolar Disorders in a Medicaid Population. Medical Care 60:2, pages 106-112.
Crossref
Crossref
Stefan Unterecker. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
235
243
.
Marie-Camille Patoz, Diego Hidalgo-Mazzei, Bruno Pereira, Olivier Blanc, Ingrid de Chazeron, Andrea Murru, Norma Verdolini, Isabella Pacchiarotti, Eduard Vieta, Pierre-Michel Llorca & Ludovic Samalin. (2021) Patients’ adherence to smartphone apps in the management of bipolar disorder: a systematic review. International Journal of Bipolar Disorders 9:1.
Crossref
Crossref
Shuang ChenJamie C BarnerEun Cho. (2021) Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016. Journal of Managed Care & Specialty Pharmacy 27:8, pages 1035-1045.
Crossref
Crossref
Afaf Hamed Khalil, Heba Hamed El Shahawi, Ahmed Saber Abdelgawad, Mai SeifElDin Abdeen, Doha Mustafa El Serafi & Sherien Ahmed Khalil. (2021) Relation of medication adherence to cognitive functions in egyptian patients with bipolar I disorder. International Clinical Psychopharmacology 36:4, pages 193-200.
Crossref
Crossref
Jens Bohlken, Steffi Riedel-Heller, Michael Bauer & Karel Kostev. (2021) Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. Pharmacopsychiatry 54:03, pages 126-130.
Crossref
Crossref
Seung Eun Lee, Nam Young Lee, Se Hyun Kim, Kyoung-Ah Kim & Yong Sik Kim. (2021) Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients. Psychiatry Research 299, pages 113830.
Crossref
Crossref
Xiaoli Niu, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, Phani Veeranki, Michael Tocco & G. Rhys Williams. (2021) Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data. Current Therapeutic Research 94, pages 100629.
Crossref
Crossref
Rosario J. Marrero, Ascensión Fumero, Adelia de Miguel & Wenceslao Peñate. (2020) Psychological factors involved in psychopharmacological medication adherence in mental health patients: A systematic review. Patient Education and Counseling 103:10, pages 2116-2131.
Crossref
Crossref
Mirko Dai Prà. (2020) Uno studio di caso di paziente con Disabilità Intellettiva e disturbo Bipolare in contesto residenziale: comportamenti aggressivi, furto, Qualità della Vita e terapia farmacologica. Un intervento Comportamentale e Cognitivo.. RIVISTA SPERIMENTALE DI FRENIATRIA:2, pages 115-140.
Crossref
Crossref
Yoo Hyun Um, Tae-Won Kim, Ho-Jun Seo, Seung-Chul Hong, Sung-Min Kim, Ji-Hye Oh & Jong-Hyun Jeong. (2020) Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics. International Clinical Psychopharmacology 35:5, pages 263-269.
Crossref
Crossref
Jens Bohlken, Michael Bauer & Karel Kostev. (2020) Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018. Psychiatry Research 289, pages 112965.
Crossref
Crossref
Maria Faurholt-Jepsen, Mads Frost, Ellen Margrethe Christensen, Jakob Eyvind Bardram, Maj Vinberg & Lars Vedel Kessing. (2020) Validity and characteristics of patient-evaluated adherence to medication via smartphones in patients with bipolar disorder: exploratory reanalyses on pooled data from the MONARCA I and II trials. Evidence Based Mental Health 23:1, pages 2-7.
Crossref
Crossref
Jens Bohlken, Marcel Konrad & Karel Kostev. (2020) Adherence to neuroleptic treatment in psychiatric practices: A retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany. Psychiatry Research 284, pages 112758.
Crossref
Crossref
Stefan Unterecker. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
9
.
M. Bauer, T. Glenn, M. Alda, R. Bauer, P. Grof, W. Marsh, S. Monteith, R. Munoz, N. Rasgon, K. Sagduyu & P. C. Whybrow. (2019) Trajectories of adherence to mood stabilizers in patients with bipolar disorder. International Journal of Bipolar Disorders 7:1.
Crossref
Crossref
Swarndeep Singh, Saurabh Kumar, Pankaj Mahal, Anuranjan Vishwakarma & Raman Deep. (2019) Self-reported medication adherence and its correlates in a lithium-maintained cohort with bipolar disorder at a tertiary care centre in India. Asian Journal of Psychiatry 46, pages 34-40.
Crossref
Crossref
Vicki C. Fung, Lindsay N. Overhage, Louisa G. Sylvia, Noreen A. Reilly-Harrington, Masoud Kamali, Keming Gao, Richard C. Shelton, Terence A. Ketter, William V. Bobo, Michael E. Thase, Joseph R. Calabrese, Mauricio Tohen, Thilo Deckersbach & Andrew A. Nierenberg. (2019) Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors. Journal of Affective Disorders 257, pages 17-22.
Crossref
Crossref
Pernille Kempel Ellegaard, Rasmus Wentzer Licht, René Ernst Nielsen, Olivia May Dean, Michael Berk, Henrik Enghusen Poulsen, Mohammadreza Mohebbi & Connie Thuroee Nielsen. (2019) The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study. Journal of Affective Disorders 245, pages 1043-1051.
Crossref
Crossref
Miriam Larsen-Barr, Fred Seymour, John Read & Kerry Gibson. (2018) Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success. Psychiatry Research 270, pages 365-374.
Crossref
Crossref